End-complementary polymerase reaction

• US 5,834,252 A
• Filed: 04/18/1995
• Issued: 11/10/1998
• Est. Priority Date: 04/18/1995
• Status: Expired due to Term

• Current Assignee: Codexis, Inc., Glaxo Group Limited (GSK plc), Affymetrix, Inc. (Thermo Fisher Scientific Incorporated)
• Original Assignee: Glaxo Group Limited (GSK plc)
• Inventors: Lipshutz, Robert J., Stemmer, Willem Peter Christiaan
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): Tung, Joyce
• Application Number:
  US08/425,684
• Time in Patent Office: 1,302 Days
• Field of Search: 435/91.2, 435/91.1, 435/91.52, 435/195, 536/24.3
• US Class Current: 435/91.1
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12Q 1/6853 using modified primers or templates
• CPC Class Codes: C12Q 2525/151 repeat or repeated sequences, e.g. VNTR, microsatellite, concatemer
• CPC Class Codes: C12Q 2525/155 incorporating/generating a new priming site
• CPC Class Codes: C12Q 2531/125 Rolling circle

Abstract

The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof and for assembling large polynucleotides from component polynucleotides, each involving generating concatemers formed by PCR amplification of overlapping fragments.

Claims

1. A method for amplifying a target polynucleotide, comprising:

contacting under conditions suitable for PCR, target polynucleotide with a bivalent primer which comprises two portions of complementarity to the target polynucleotide;

(1) a first portion which is in the 5'"'"' portion of the primer and which is substantially complementary to a sequence in the 5'"'"' portion of the sequence to be amplified (target sequence) in the target polynucleotide, and (2) a second portion which is in the 3'"'"' portion of the primer and which is substantially complementary to a sequence in the 3'"'"' portion of the sequence to be amplified (target sequence) in the target polynucleotide;

catalyzing under suitable reaction conditions for PCR, polynucleotide synthesis primed from the 3'"'"'-hydroxyl of the annealed bivalent primer to form a strand complementary to the target sequence, thereby forming a nascent complementary strand;

denaturing the target polynucleotide and the nascent strand and allowing reannealing, under dilute conditions suitable for substantial intramolecular annealing and circle formation, the nascent strand with a complementary strand of a target polynucleotide or an amplified copy thereof to form amplification intermediates in the form of cyclized DNA as a result of the 3'"'"' terminus of an overlapped nascent strand annealing to the 3'"'"' terminus of an overlapped complementary strand which has a strand with an extendable 3'"'"'-hydroxyl which can be extended with a DNA polymerase substantially lacking exonuclease activity whereby the leading terminus of the nascent strand continually displaces the lagging portion of the nascent strand producing a concatemeric single strand emanating from the amplification intermediate; and

repeating an elongation/denaturation/reannealing cycle from 1 to about 100 times as desired, resulting in formation of amplified product which comprises head-to-tail concatemers of the target sequence.

2. The method of claim 1, comprising the further step of cleaving said concatemers with a restriction endonuclease which cuts within each concatemeric unit to form a population of polynucleotides each consisting of an amplified target sequence.

3. The method of claim 2, comprising the further step of ligating the population of polynucleotides each consisting of an amplified target sequence with DNA ligase to form covalently closed circles.

4. The method of claim 2, comprising the further step of ligating the population of polynucleotides each consisting of an amplified target sequence by direct transformation into host cells for in vivo ligation.

5. The method of claim 1, wherein said polynucleotide synthesis primed from the 3'"'"'-hydroxyl of the annealed primer forms a sequence-variant of the strand complementary to the target sequence.

6. The method of claim 5, wherein repeating said elongation/denaturation/reannealing cycle from 1 to about 100 times, results in a library which comprises a plurality of sequence-variants of the strand complementary to the target sequence.

7. A method of forming a polynucleotide, comprising:

(1) providing two double-stranded polynucleotides overlapping at both ends, which can be denatured to single-stranded polynucleotides having complementary ends that can anneal to generate a circular form;

(2) denaturing the double-stranded polynucleotides to generate the single-stranded polynucleotides;

(3) incubating the single-stranded polynucleotides under conditions whereby complementary ends anneal;

(4) extending the 3'"'"' ends of annealed polynucleotides, under conditions whereby each polynucleotide serves as a template for another;

(5) repeating steps (2)-(4) 1-100 times, whereby the extended polynucleotides in step (4) constitute the double-stranded polynucleotides in step (2) in the next cycle.

8. The method of claim 7, wherein one of the double stranded polynucleotides includes a variable-sequence kernel.